J011-0249 Screening compound: N-[(4-{3-methyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl}phenyl)methyl]naphthalene-1-carboxamide

J011-0249 Screening compound: N-[(4-{3-methyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl}phenyl)methyl]naphthalene-1-carboxamide
J011-0249 Screening compound: N-[(4-{3-methyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl}phenyl)methyl]naphthalene-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J011-0249
N-[(4-{3-methyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl}phenyl)methyl]naphthalene-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J011-0249

Molecular Formula

C22H17N5OS (C22 H17 N5 OS)

Compound Name

N-[(4-{3-methyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl}phenyl)methyl]naphthalene-1-carboxamide

IUPAC name

N-[(4-{3-methyl-[124]triazolo[34-b][134]thiadiazol-6-yl}phenyl)methyl]naphthalene-1-carboxamide

SMILES

Cc1nnc2sc(-c3ccc(CNC(c4cccc5ccccc45)=O)cc3)nn12

InChI

InChI=1S/C22H17N5OS/c1-14-24-25-22-27(14)26-21(29-22)17-11-9-15(10-12-17)13-23-20(28)19-8-4-6-16-5-2-3-7-18(16)19/h2-12H,13H2,1H3,(H,23,28)

InChI Key

DRJAUBSGAPFAPP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD12130026

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

399.48

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.420

Distribution Coefficient, logD

3.420

Water Solubility, LogSw

-3.66

Polar Surface Area

58.912

Acid Dissociation Constant (pKa)

14.23

Base Dissociation Constant (pKb)

0.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.10

J011-0249 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with J011-0249 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J011-0249?
Check Price and Availability of J011-0249, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J011-0249 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J011-0249
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J011-0249
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J011-0249 available by request